Home›Compare›MangoRx vs Ways2Well

MangoRx vs Ways2Well: Which Is Better?

Head-to-head comparison of MangoRx and Ways2Well based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

MangoRx scores higher overall in our independent evaluation (58/100 vs 51.8/100), leading on trust & safety, value, experience. Ways2Well comes out ahead on product range, reputation.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
52
Ways2Well
Below Average

Lab-first longevity and hormone practice with telehealth in 46 states plus DC and physical clinics in Austin and Houston, founded by Revive Rx Pharmacy owner Brigham Buhler.

Visit Ways2Well

Score Breakdown

DimensionMangoRxWays2Well
Overall Score58/100 ✓51.8/100
Trust & Safety30%55/100 ✓45/100
Value25%62/100 ✓50/100
Experience20%58/100 ✓50/100
Product Range15%66/10072/100 ✓
Reputation10%45/10050/100 ✓

At a Glance

Founded2021—
HeadquartersDallas, TXAustin, TX
Publicly tradedYes (MGRX)No
Treatment categories56
Treatments listed54
Starting price$50/mo$125/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxWays2Well
Men's Health——
Hormone Therapy$99
Injectable TRT (testosterone cypionate)
—
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
—

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Ways2Well

+Lab-first model: every care plan includes a comprehensive blood panel reviewed by a clinician before anything is prescribed
+Care-plan pricing is published ($499 one-time Clarity; $125/mo or $1,499/yr Core), and there is a free 20-minute RN call
+Broad scope spanning TRT, women's hormones, peptides, supplements and testing, plus in-person clinics in Austin and Houston
−Founder-owned Revive Rx Pharmacy got an FDA warning letter (Sept 22, 2025) for insanitary sterile compounding and has FDA inspection reports from 2022, 2025 and 2026; reviewers say it fills Ways2Well orders
−Markets unapproved regenerative services (stem cells, Muse cells, EBOO, plasmapheresis) alongside its telehealth offering
−Prices for prescriptions and peptides are not published; peptides require a separate $99 consult and are billed on top
Read the full Ways2Well review →

MangoRx vs Ways2Well — FAQ

Is MangoRx better than Ways2Well?

▾

MangoRx scores higher overall in our independent evaluation (58/100 vs 51.8/100), leading on trust & safety, value, experience. Ways2Well comes out ahead on product range, reputation.

Is MangoRx or Ways2Well cheaper?

▾

MangoRx has the lower starting price (from $50/mo vs $125/mo for Ways2Well). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Ways2Well both offer?

▾

Both platforms treat Men's Health, Hormone Therapy, Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and Ways2Well covers 6.

Still deciding?